Effectiveness of Early Use of Erenumab vs Nonspecific Oral Migraine Preventives
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Early Use of Erenumab vs Nonspecific Oral Migraine Preventives: The APPRAISE Randomized Clinical Trial
JAMA Neurol 2024 Mar 25;[EPub Ahead of Print], P Pozo-Rosich, D Dolezil, K Paemeleire, A Stepien, P Stude, J Snellman, M Arkuszewski, T Stites, S Ritter, CL Lopez, J Maca, M Ferraris, R Gil-GouveiaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.